Director, RWE

Vertex Health Economics jobs

Boston, MA, US. The Director, Real World Evidence leads the successful execution of studies in accordance with RWE, Disease area, Program and Enterprise goals as well as ensuring the reliable tracking and reporting of RWE studies, analyses and resource use.  As an integral member of the RWE team, the RWE Director leverages subject matter expertise in their disease portfolio to … Read more

Senior Director, Pipeline Head for Immunology, Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

West Chester, PA / Parsippany, NJ, US. The ideal candidate will need to be based out of our West Chester, Pennsylvania or Parsippany, New Jersey.  The goals and objectives of the Global Health Economics, Value, and Outcomes department is to develop robust value and evidence strategies supportive of the value of pipeline and BD assets in clinical development; formulate evidence-based … Read more

European HEOR & RWE Senior Manager

Jobs at Daiichi Sankyo for Health Economists

Europe. We are seeking highly qualified candidates to fill the position: European Health Economics Outcomes Research & Real World Evidence Senior Manager Oncology (m/f/x). The Position: The Senior Manager HEOR & RWE leads the development of the European HEOR and RWE strategy for the product(s) he/she is responsible for, in order to maximize the outcomes in terms of Market Access … Read more

Senior Director, Pipeline Head for Immunology, Global Health Economics, Value, & Outcomes

Teva pharmaceuticals health economics jobs

Harlow, UK / Amsterdam, Netherlands. Other locations: West Chester, PA; Parsippany, NJ, US. The goals and objectives of the Global Health Economics, Value, and Outcomes department is to develop robust value and evidence strategies supportive of the value of pipeline and BD assets in clinical development; formulate evidence-based value propositions that are aligned with Teva assets and products and have … Read more

Global Health Economics Specialist, Devices

Jobs at G&J Lee Recruitment for Health Economists

Home-based, UK / France. Other locations: Netherlands; Germany. Location: Home-based position within the UK, France, Netherlands or Germany. Salary: £60k-£70k plus package including 15% bonus and comprehensive benefits package. Company: Global medical device manufacturer with a market leading product portfolio. I am pleased to be working again with the Global HEOR & Market Access team of a very successful MedTech … Read more

Senior RWE Scientist

Jobs at AstraZeneca for Health Economists

Barcelona, Spain. We are looking for MSc/PhD level epidemiologists, bio-statisticians, biomedical data scientists, clinicians/pharmacologists or related fields with a strong desire to learn and expand their abilities into the analysis of Real World Evidence (RWE). The ideal candidate for this role will have deep understanding of epidemiology and will bring a consistent track record of delivering value through the use … Read more

(Sr.) Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Singapore. Provides high quality, timely development and on-time input to client solutions for the pharmaceutical and related industries. Assignments range in complexity from basic analysis and problem solving to assisting in the development of more complex solutions to leading small teams. Principal Accountabilities: Minimum Education, Experience Required: IQVIA™ is The Human Data Science Company™, focused on using data and science … Read more

Associate Director RWE

Merck jobs for Health Economists

Darmstadt, Germany. An exciting opportunity awaits you within the Patient Focused Real World Evidence (PRWE) Team for Oncology (Early Phase Development). As passionate leaders of patient focused real world data, evidence generation, and epidemiology, we are uniquely placed to enable fit-for-purpose visionary solutions. Our team operates with a proactive and agile approach, as a trusted partner in qualitative and quantitative … Read more

Associate Principal Health Economics

Health Economists jobs at IQVIA

Milan, Italy. IQVIA Italy is searching for a new senior member for joining the Real-World Solution team. This is a leadership position with business development responsibilities, for which exceptional technical expertise is required. Leadership and business development activities related to Health Economics: Management of complex projects: Qualifications And Skills: IQVIA is a leading global provider of advanced analytics, technology solutions … Read more

(Sr.) Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Petaling Jaya, Malaysia. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement … Read more

Assistant Director – RWE Retrospective Analysis

Jobs at AmerisourceBergen for Health Economists

Home-based, TX, US. In collaboration with project engagement leads, the candidate will provide clinical and statistical programming expertise to health economics and outcomes research studies to support pharmaceutical, biotech, and device technologies. The candidate will serve as the content developer for the implementation and reporting of burden of illness, comparative effectiveness, health resource utilization and cost studies and other database … Read more

RWE Advisor

Jobs at Novo Nordisk for Health Economists

Bangkok, Thailand. Do you want to be an integral member of one of the fastest-growing multinational pharma companies in Thailand? Novo Nordisk has opened a role for Real World Evidence Advisor, based in Bangkok, Thailand. Be part of our life-changing careers and apply now! The Position In this role, you will oversee managing real-world evidence strategic planning, execution and analyses … Read more

Director, RWE Partnerships & Innovation

Pfizer Health Economists jobs

Tokyo, Japan / Seoul, South Korea. Other location: Mapletree Business City, Singapore. The Platform: The Chief Medical Affairs Office’s  RWE Partnerships and Platforms organization is responsible for establishing global RWE data and scientific leadership through the generation of integrated, end-to-end observational real-world evidence serving all therapeutic areas from proof of concept (POC) trials through LOE for priority pipeline candidates, pipeline … Read more

Global Associate Director HEOR

Astellas jobs for Health Economists

UK. This role is part of the Global HEOR Oncology team reporting to the Executive Director HEOR (Oncology). As the Global Associate Director HEOR Real World Evidence, you will focus on creating and advising on global tactics/strategy for Evidence Generation, encompassing RWE analysis, ensuring that HEOR perspectives and strategies across geographies, are integrated within the core medical plans, integrated global … Read more

Analyst – Assoc Consultant, HEOR, Real World Solutions

Health Economists jobs at IQVIA

Singapore. Our HEOR team includes highly qualified multi-disciplinary experts. They are based throughout Asia with a focused footprint in the SEA. The HEOR practice is part of the IQVIA Real-World Insights business unit that connects healthcare stakeholders through knowledge, skills, practical experience, creativity and data to demonstrate the value of medicines, enhance quality of care and drive improvement of patient … Read more

Real-World Evidence in Health Economics

RWE jobs in Health Economics
Real-World Evidence in Health Economics

Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.

What is Real-World Evidence?

Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.

RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.

Importance of Real-World Evidence in Health Economics

RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.

RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.

Differences between RWE and Randomized Controlled Trials (RCTs)

RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.

RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.

RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.

Methods of Collecting RWE

There are several methods of collecting RWE, including:

Electronic Health Records (EHRs)
EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.

Claims Databases
Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.

Registries
Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.

Patient-Reported Outcomes (PROs)
PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.

Surveys
Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.

Advantages of Real-World Evidence

There are several advantages of using RWE in health economics research, including:

  • RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
  • RWE can be used to evaluate interventions in a variety of settings and patient populations.
  • RWE can provide information on the long-term effectiveness and safety of interventions.
  • RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.

Challenges and Limitations of Real-World Evidence

There are several challenges and limitations to using RWE in health economics research, including:

  • RWE can be subject to bias and confounding, which can affect the validity of the results.
  • RWE can be difficult to collect and analyze, particularly when using multiple data sources.
  • RWE may not be as well-suited for evaluating rare diseases or interventions.

Applications of Real-World Evidence

RWE has several applications in health economics research, including:

Health Technology Assessment
Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.

Comparative Effectiveness Research
Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.

Post-Marketing Surveillance
Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.

Future of Real-World Evidence in Health Economics

RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.